Arkolith/Insider Trading/ANRO/Form 4

Smith Nicholas Conrad

CHIEF FINANCIAL OFFICER & CBOAlto Neuroscience, Inc. (ANRO) · full profile →Form 4 · filed Jul 8, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 3, 2025Disposed to issuer(D)45K——0
Jul 3, 2025Grant(A)45K——45K
Jul 3, 2025Grant(A)34K——34K
Jul 3, 2025Disposed to issuer(D)34K——0
Jul 3, 2025Grant(A)202K——202K
Jul 3, 2025Disposed to issuer(D)202K——0
Jul 3, 2025Grant(A)90K——90K
Jul 3, 2025Disposed to issuer(D)90K——0
Jul 3, 2025Grant(A)135K——135K
Jul 3, 2025Disposed to issuer(D)135K——0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001999480-25-000062) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Alto Neuroscience, Inc.

Build

Ask your agent about ANRO insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001999480-25-000062"
Ask your agent
Use Arkolith to summarize insider buying and selling at Alto Neuroscience, Inc.
over the last 90 days and cite the filings.